8-KOther Events

Elevance Health, Inc. 8-K Report (Jun 17, 2002)

Filed June 17, 2002For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) issued this 8-K on June 17, 2002, to inform investors about upcoming meetings with securities analysts and investors. The primary purpose of these meetings was to confirm the company's ability to meet previously stated earnings expectations, which were detailed in a press release and conference call on April 29, 2002. This filing reiterates management's confidence in achieving its financial targets for the period. While the filing itself does not introduce new financial data, it serves as a confirmation of forward-looking statements. Investors should note the extensive cautionary language regarding risks and uncertainties that could impact actual results, including factors such as healthcare cost trends, regulatory changes, competitor actions, and the integration of the Trigon Healthcare acquisition. The company highlighted its ongoing efforts to manage these risks and achieve its strategic objectives.

Key Highlights

  • 1Confirmation of ability to meet previously issued earnings expectations for the period.
  • 2Management's confidence in achieving financial targets will be communicated to analysts and investors.
  • 3Meetings with securities analysts and investors are scheduled for the week of June 17, 2002.
  • 4Reference to a prior press release and conference call (April 29, 2002) that provided earnings expectations.
  • 5Extensive discussion of forward-looking statements and associated risks and uncertainties.
  • 6Specific mention of the ongoing Trigon Healthcare acquisition and its potential impact on synergies and integration.

Frequently Asked Questions

The main purpose of this 8-K filing is to inform investors and securities analysts that Elevance Health (then Anthem, Inc.) management planned to meet with them during the week of June 17, 2002, to confirm the company's ability to meet its previously announced earnings expectations.

No, this filing does not provide new financial results or updated guidance. Instead, it confirms management's intention to reiterate their confidence in meeting the earnings expectations that were previously communicated in a press release and conference call on April 29, 2002.

The filing lists several risks, including trends in healthcare costs and utilization, the ability to secure premium rate increases, competitor pricing, increased government regulation, significant competitor acquisitions/divestitures, new drug/technology utilization, financial strength rating downgrades, litigation, provider contracting, successful integration of the Trigon Healthcare acquisition, and general economic downturns.

The filing refers to the anticipated completion of Anthem's acquisition of Trigon Healthcare, Inc. It highlights that achieving expected synergies and operating efficiencies, as well as successful integration, are key factors that could impact future performance. The company's ability to consummate this transaction is listed as a significant risk factor.